Skip to main content

cancer drug Archives

New study illustrates how much it would cost for cancer drugs covered under Medicare Part D

May. 10, 2022—A new study by Vanderbilt researchers highlights how some older Americans diagnosed with cancer can face unlimited out-of-pocket spending for prescription drugs under the current structure of the Medicare Part D benefit.

Read more


Study finds generic options offer limited savings for expensive drugs

May. 9, 2018—Generic drug options did not reduce prices paid for the cancer therapy imatinib (Gleevec), according to a Health Affairs study released this week.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more